Literature DB >> 1527386

Surface contact requirements for activation of cytotoxic T lymphocytes.

M F Mescher1.   

Abstract

Cell activation resulting from binding of receptors on one cell to ligands on another is governed by receptor affinities and by ligand concentrations. Effective ligand concentration is determined by its density on the cell surface, but receptor occupancy level will also be influenced by the area of surface contact between the cells. The present study demonstrates the critical importance of a large, continuous surface contact area for effective CTL activation. Using class I alloantigen immobilized on latex microspheres, particle sizes of 4 to 5 microns were found to provide an optimum stimulus. Below 4 microns, responses decreased rapidly with decreasing particle size, and large numbers of small particles could not compensate for suboptimal size. Comparable size dependence was found for activation of degranulation by cloned CTL and for stimulation of in vitro generation of CTL responses by spleen cells from in vivo primed mice. In the presence of fluid-phase anti-TCR antibody, CD8-dependent binding to non-Ag class I (i.e., class I that is not recognized by the TCR) can provide a costimulatory signal to activate degranulation. This response is also critically dependent upon the class I being presented on a particle of 4 or 5 microns diameter. The results suggest that sufficient receptor occupancy (both TCR and CD8) over a contiguous region of the cell surface, as opposed to total interactions over the entire cell surface, is a critical determinant for activation. The ability of CTL to distinguish between Ag on cell-size vs subcellular fragments is probably necessary for their effective functioning, and may also explain the inability to significantly influence CTL activation in vivo with subcellular or soluble forms of Ag.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527386

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling.

Authors:  B Ybarrondo; A M O'Rourke; J B McCarthy; M F Mescher
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Signaling at neuro/immune synapses.

Authors:  Michael L Dustin
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

3.  Energy of adhesion of human T cells to adsorption layers of monoclonal antibodies measured by a film trapping technique.

Authors:  I B Ivanov; A Hadjiiski; N D Denkov; T D Gurkov; P A Kralchevsky; S Koyasu
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

4.  Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

Authors:  A D Santin; P L Hermonat; A Ravaggi; S Bellone; S Pecorelli; J J Roman; G P Parham; M J Cannon
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Janus particles as artificial antigen-presenting cells for T cell activation.

Authors:  Bo Chen; Yilong Jia; Yuan Gao; Lucero Sanchez; Stephen M Anthony; Yan Yu
Journal:  ACS Appl Mater Interfaces       Date:  2014-10-28       Impact factor: 9.229

Review 6.  Nanoengineering approaches to the design of artificial antigen-presenting cells.

Authors:  Joel C Sunshine; Jordan J Green
Journal:  Nanomedicine (Lond)       Date:  2013-07       Impact factor: 5.307

Review 7.  Nanoscale artificial antigen presenting cells for cancer immunotherapy.

Authors:  Kelly R Rhodes; Jordan J Green
Journal:  Mol Immunol       Date:  2018-03-07       Impact factor: 4.407

8.  Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.

Authors:  Joel C Sunshine; Karlo Perica; Jonathan P Schneck; Jordan J Green
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

9.  Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanoma.

Authors:  Gautam Jha; Jeffrey S Miller; Julie M Curtsinger; Yan Zhang; Mathew F Mescher; Arkadiusz Z Dudek
Journal:  Am J Clin Oncol       Date:  2014-06       Impact factor: 2.339

10.  T cell antigen receptor signaling and immunological synapse stability require myosin IIA.

Authors:  Tal Ilani; Gaia Vasiliver-Shamis; Santosh Vardhana; Anthony Bretscher; Michael L Dustin
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.